Translator Disclaimer
1 June 2005 Yeast-Derived Sigma C Protein-Induced Immunity Against Avian Reovirus
Author Affiliations +

Avian reoviruses (ARVs) can result in disease and economic losses in the poultry industry. Vaccines against ARV may not provide full protection and can cause adverse reactions. The coding sequence of the sigma C protein from strain S1133 of avian reovirus was expressed in Schizosaccharomyces pombe. Sigma C protein expression was demonstrated by Western blotting, and the protein was evaluated for its ability to protect specific-pathogen-free (SPF) chickens against challenge with the virulent S1133 strain. Serologic and challenge-infection data showed the efficacy of the recombinant vaccine administered orally each week for 3 consecutive wk. Sigma C protein induced antibody, as determined by enzyme-linked immunosorbent assay. Percentage (%) protection induced by the low dose (125 μg purified yeast-expressed sigma C protein/chicken) or the high dose (250 μg purified yeast-expressed sigma C protein/chicken) was 64 and 91, respectively. The commercial vaccine administered once or twice provided 82% protection. Results supported the feasibility of a plant-derived vaccine for use in poultry immunization schemes.

H. Wu, Y. Williams, K. S. Gunn, N. K. Singh, R. D. Locy, and J. J. Giambrone "Yeast-Derived Sigma C Protein-Induced Immunity Against Avian Reovirus," Avian Diseases 49(2), 281-284, (1 June 2005).
Received: 29 September 2004; Accepted: 1 February 2005; Published: 1 June 2005

Get copyright permission
Back to Top